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Cationic Mn(III) porphyrin complexes based on MnTM-2-PyP are among the most promising superoxide
dismutase (SOD) mimicking compounds being considered as potential anti-inﬂammatory drugs. We
studied four of these active compounds in the yeast Saccharomyces cerevisiae, MnTM-2-PyP, MnTE-2-PyP,
MnTnHex-2-PyP, and MnTnBu-2-PyP, each of which differs only in the length of its alkyl substituents.
Each was active in improving the aerobic growth of yeast lacking SOD (sod1Δ) in complete medium, and
the efﬁcacy of each mimic was correlated with its characteristic catalytic activity. We also studied the
partitioning of these compounds between mitochondria and cytosol and found that the more hydro-
phobic members of the series accumulated in the mitochondria. Moreover, the degree to which a mimic
mitigated the sod1Δ auxotrophic phenotype for lysine relative to its auxotrophic phenotype for
methionine depended upon its level of lipophilicity-dependent accumulation inside the mitochondria.
We conclude that localization within the cell is an important factor in biological efﬁcacy in addition to
the degree of catalytic activity, and we discuss possible explanations for this effect.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The intracellular superoxide dismutase enzymes (SODs)—cop-
per–zinc SOD (CuZnSOD or SOD1p), found in the mitochondrial
intermembrane space (IMS), cytoplasm, and nucleus, and manga-
nese SOD (MnSOD, SOD2), found in the mitochondrial matrix—
catalyze the disproportionation of superoxide to hydrogen per-
oxide and dioxygen. They represent a major antioxidant defense
system in eukaryotic cells [1]. In the case of the budding yeast
Saccharomyces cerevisiae, Sod1p in particular has been found to be
critical for cell ﬁtness since sod1Δmutant yeast strains lacking this
defense mechanism exhibit dioxygen sensitivity, poor growth in
air, altered energy metabolism, and auxotrophies for lysine,
methionine, and leucine [2,3]. The lysine and leucine auxotrophies
are believed to result from inactivation of superoxide-sensitive
iron–sulfur cluster-containing dehydratases in their biosynthetic
pathways [4,5]. The enzyme homoaconitase on the biosyntheticB.V. This is an open access article u
).
icine, New Haven, CT, USA.pathway for lysine is related to the TCA cycle enzyme aconitase;
both are much decreased in activity in sod1Δ yeast and both are
mitochondrial. The FeS cluster enzyme implicated in leucine
auxotrophy, Leu1p, is cytoplasmic. Mutants of the ﬁssion yeast
Schizosaccharomyces pombe that lack cytoplasmic CuZnSOD also
show a lysine auxotrophy. Interestingly, in this organism the
auxotrophy was attributed to inactivation of homocitrate synthase,
the enzyme upstream of homoaconitase in the lysine pathway [6].
Interestingly, CuZnSOD is also involved in control of respiration
rate, being part of a glucose repression pathway that reduces
respiration even in the presence of oxygen [7].
Alterations in superoxide metabolism have been linked to a large
variety of human pathologies, including accelerated aging and
neurodegenerative disease [8,9], leading to an interest in develop-
ment of drugs that could provide protection against the effects of
elevated oxidative stress. A variety of SOD-mimicking compounds
have been developed and explored for their effectiveness in treating
oxidative stress-related pathologies [10,11]. One of the most pro-
mising classes of these potential drugs is a series of cationic Mn(III)
porphyrins (MnPs, [12]). The most effective SODmimics in this class
(Diagram 1) have the meso positions of their porphyrin rings
substituted with ortho-N-alkylpyridinium substituents [13,14].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. The structures of Mn(III) porphyrin-based SOD mimics.
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nitrogens was chosen to adjust thermodynamic and kinetics for the
−O2
. dismutation and to hinder the planar MnP ring sterically from
interacting substantially with DNA and RNA, thereby improving its
catalytic efﬁciency in vivo.
A survey in yeast and Escherichia coli comparing the biological
activities of several diverse SOD mimics of different classes found
that only the cationic Mn porphyrins could substitute for the bona
ﬁde SOD enzyme and facilitate the aerobic growth of yeast lacking
CuZnSOD (sod1Δ) [15]. The two compounds of that class used in
that study were MnTM-2-PyP5þ and MnTE-2-PyP5þ , both cationic
MnPs with ortho N-alkylpyridinium groups substituted at themeso
positions (see Fig. 1). Both compounds demonstrated considerable
capacity to restore sod1Δ growth under aerobic conditions.
Speciﬁcally, Mn-TM2-PyP restored growth in air to wild type
levels, even in media lacking methionine or lysine in which the
sod1Δ strain does not normally grow at all.
In the current study, we explore four of the cationic MnP-based
SOD mimics in this series that differ only in the length of the
substituents at the ortho position. The N-alkylpyridinium groups for
each compound differ according towhether methyl-(MnTM-2-PyP5þ),
ethyl-(MnTE-2-PyP5þ), n-butyl-(MnTnBu-2-PyP5þ), or n-hexyl-
(MnTnHex-2-PyP5þ) hydrocarbon chain ends have been attached to
the four pyridyls (Fig. 1). The larger N-alkyl groups enhance the
lipophilicity and thus the ability of the Mn porphyrin, which carries
overall positive charge, to penetrate cell membranes. The compound’s
lipophilicity inﬂuences both its intracellular availability and the range
of concentrations over which it improves the growth of SOD-deﬁcient
bacteria and/or inhibits the growth of SOD-replete bacteria [14,16].
Our results indicate that each of these four MnP-based mimics indeed
provides beneﬁcial effects to the growth of sod1Δ yeast in an aerobic
environment and that the potency in substituting for the SOD enzyme
depends largely on its characteristic catalytic activity. We ﬁnd further
that the increasing lipophilicity of a mimic correlates positively with
its degree of localization to the mitochondria relative to the cytosol,
and that this localization inﬂuences the capacity of a mimic to mitigate
the lysine relative to the methionine auxotroph of sod1Δ yeast.Methods
Yeast strains and pre-culture conditions
The wild-type S. cerevisiae strain used was EG103, (MATα, leu2,
his3, trp1, ura3). The sod1Δ mutant strain was EG118, (MATα, leu2,
his3, trp1, ura3, sod1Δ::URA3) was derived from it by gene
replacement [17]. For growth experiments cells were ﬁrst streaked
from 20% glycerol stocks onto yeast extract, peptone, 2% dextrose
agar (YPD) [18] and incubated for 72 h at 30 °C under conditions of
low oxygen. Single colonies were then selected to grow overnight
at 30 °C in synthetic complete liquid medium supplemented with
2% dextrose (SDC) as described [17]. All synthetic dextrose (SD)
liquid media were adjusted to pH 6.0 unless otherwise noted.
Growth experiments
Growth of the yeast cells was measured using cultures' absor-
bance (optical density) at 600 nm (A600 or OD600; a value of 1 is
equivalent to 1107 cells/mL). Cells from overnight pre-cultures
were inoculated into 10 mL of liquid SDC, SD-Lys, or SD-Met
(speciﬁc amino acids that were omitted from media are indicated)
in 50 mL ﬂasks at an initial OD600 of 0.05 and grown at 30 °C,
shaking at 220 rpm under aerobic conditions. All media were
treated with MnP concentrations as indicated. Error bars denote
standard deviations.
Manganese porphyrin SOD mimics
MnTE-2-PyP5þ , MnTM-2-PyP5þ , MnTnHex-2-PyP5þ , and
MnTnBu-2-PyP5þ (Fig. 1), were synthesized as described [13],
and ﬁlter sterilized with a 0.22 mm ﬁlter (Whatman, Middlesex,
UK) before utilization in experimental procedures.
Toxicity assay procedure
Wild-type yeast cells from overnight pre-cultures were inocu-
lated at 0.05 OD600 into 10 mL SDC pH 6.0 in 50 mL ﬂasks and
incubated at 220 rpm, 30 °C until they reached an OD600 of 0.5–2
(log phase). The cells were then spun down, washed with water,
and resuspended at 0.1 OD600 in glass tubes containing 0.5 mL
water or SDC with varying concentrations of SOD mimics. Cells
were aerobically incubated under these conditions for 1–2 h
before being diluted and plated onto YPD agar, on which they
were allowed to grow for 48 h.
Mitochondrial and cytosolic isolation procedure
Wild-type yeast cells from overnight pre-cultures were inocu-
lated at 0.1 OD600 into 500 mL SDC pH 6.0 containing the indicated
MnP at 10 mM. After growing at 220 rpm at 30 °C under aerobic
conditions in this medium for 18–24 h, the cells were harvested
and spun down for 5 min at 3500 rpm. Mitochondria were isolated
as described by [19]. During this mitochondrial puriﬁcation
process, cytosolic fractions of the wild-type yeast were collected
from supernatants immediately after the ﬁrst 10 min, 10,000 rpm
pelleting step.
Measurements of manganese porphyrin SOD mimic using liquid
chromatography electrospray ionization tandem mass spectrometry
(LC/ESI-MS/MS)
Measurements were performed in PK/PD Shared Resource of
Duke Cancer Institute. Samples to be measured were ﬁrst prepared
by adding 25 mL of cytosol or mitochondrial homogenate, 25 mL of
water, and 5 mL of 5 mM internal standard solution in water (see
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Fig. 2. Effect of Mn TE-2-PyP5þ , MnTnBu-2-PyP5þ and MnTnHex-2-PyP5þ on
growth of sod1Δ yeast under aerobic conditions. Cultures were grown for 24 h at
30 °C, shaking at 220 rpm in SDC with mimic concentrations as indicated. Cell
density was measured using turbidity of cultures at 600 nm. The values presented
are averages of three independent yeast cultures grown on the same day, with error
bars signifying standard deviation. Student 2-tailed T-tests were performed; the
difference between control and each experimental point was signiﬁcant (Po0.05).
Representative experiments are shown (* not tested.).
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After letting this mixture stand at room temperature for 10 min,
100 mL of 1% acetic acid in methanol was added. Next, the sample
was vigorously mixed (Fast Prep, 40 s, speed 6) and left at 20 °C
for 15 min. The sample was then centrifuged at 16,000g at 4 °C for
15 min. To prepare sample for injection into LC/MS/MS system,
100 mL of supernatant was pipetted into 5 mL-polypropylene
round-bottom tube, which was placed in rotary evaporator (Speed
Vac) at 50 °C for 1 h. Residue remaining after evaporation was
dissolved in 100 mL mobile phase A (see LC conditions below),
spun for 5 min at 16,000g in 4 °C. Of this ﬁnal mixture, 20 mL was
injected into LC/MS/MS system.
LC conditions
A Shimadzu 20A series high pressure liquid chromatography
system (HPLC) was used, with a Phenomenex 43 mm2 C18 guard
cartridge analytical column. The column temperature was main-
tained at 35 °C. Mobile phase A was 5% acetonitrile and 0.0005%
heptaﬂuorobutyric acid, HFBA. Mobile phase B was acetonitrile,
which had the following elution gradient: 0–0.2 min 0–90% B, 0.2–
0.7 min 90% B, 0.7–0.75 min 90–100% B. Run time was 4 min.
MS/MS conditions
The mass spectrometer used was Applied Biosystems MDS
Sciex 3200 Q Trap or 4000 Q Trap ESI-MS/MS. MRM transitions
observed were as follows (parent ion [MnP5þþ3HFBA]2þ/2):Mn
Mn
Mn
MnAnalyte Internal standardTM-2-PyP5þ , m/z 685.3/
356.6MnTE-2-PyP5þ , m/z 713.3/
363.6TE-2-PyP5þ , m/z 713.3/
363.6MnTM-2-PyP5þ , m/z 685.3/
356.6TBu-2-PyP5þ , m/z 769.3/
398.8MnTnHex-2-PyP5þ , m/z 825.5/
611.5TnHex-2-PyP5þ , m/z
825.5/611.5MnTnHep-2-PyP5þ , m/z 853.5/
639.5.4
6
8
en
si
ty
 (O
D
60
0)
0
2
4
6
8
10
O
D6
00
C -M -K
WT growth
medium:
sod1∆ growth
Sample calibrations, in which known amounts of pure analytes
are mixed with cellular homogenates and analyzed in conjunction
with experimental samples, occurred in the 1–300 nM or 0.1–
30 mM range. For the concentrations used, a linear response was
observed.
A Bradford Protein Assay Kit (Bio-Rad) was used to determine
the protein concentrations, which were used to normalize the Mn
porphyrin mimic concentrations determined using HPLC.0
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Fig. 3. sod1Δ S. cerevisiae aerobic growth in SD-Met (-M, green bars), SD-Lys (-K,
orange bars) or SD-complete (C, black bars). Cells were inoculated at low density,
treated (or not) with 30 mM MnTM-2-PyP5þ (TM), MnTE-2-PyP5þ (TE),
MnTnBu-2-PyP5þ (Bu), or MnTnHex-2-PyP5þ (Hex), and incubated at 30 °C and
220 rpm for 24 h, after which cell density was determined. Values shown are the
averages calculated from three independent colonies, with error bars representing
standard deviation. Student 2-tailed T-tests were performed. There is no signiﬁcant
difference between WT growth (inset) in the three media. For sod1Δ, the
differences are signiﬁcant (Po0.05) between complete and drop out media;
between treated and no mimic samples in all cases; and between samples grown
in -Met and -Lys in the case of TE and Hex.Results
In this study, we ﬁrst assessed the potency of the new Mn
porphyrins by examining their effects on the aerobic growth of
sod1Δ S. cerevisiae. In a previous study [15], it was shown that
MnTM-2-PyP5þ and MnTE-2-PyP5þ signiﬁcantly improved the
growth of sod1Δ yeast in SDC. We now extend these data to
include MnTnBu-2-PyP5þ and MnTnHex-2-PyP5þ . Fig. 2 shows
that the new compounds improve growth of sod1Δ yeast in
synthetic complete medium (SDC) to approximately the same
extent as MnTE-2-PyP5þ .
To explore further the relative efﬁcacy of these Mn porphyrin
mimics in vivo, we tested their ability to improve the growth of
sod1Δ yeast in medium lacking lysine or methionine (SD-Lys or
SD-Met). These conditions are far more stringent, as sod1Δ yeast
show little or no growth in these media. The data presented inFig. 3 showed that both MnTnHex-2-PyP5þ and MnTE-2-PyP5þ
consistently rescued the growth of the sod1Δ in SD-Lys signiﬁ-
cantly more than in SD-Met. In contrast, MnTM-2-PyP5þ and
MnTnBu-2-PyP5þ restored the growth of these mutant yeast
auxotrophic phenotypes to the same extent in both media,
although the TM compound was far more effective in both.
The methionine-synthesizing pathway uses a large amount of
NADPH, and its sensitivity to superoxide stress is believed to be
due to depletion of NADPH in the cytosol in sod1Δ yeast [20]. On
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Fig. 5. Degree of mitochondrial localization of Mn porphyrin mimic vs. compound
lipophilicity (denoted by Rf value) for four trials. Wild-type S. cerevisiae treated
with the four mimic compounds were grown as described in Fig. 3. The degree of
mitochondrial localization was calculated by dividing the Mn porphyrin mimic
concentration to protein concentration ratio of the mitochondrial fraction by that of
the cytosolic fraction from wild-type yeast cells treated with the indicated Mn
porphyrin mimic for each trial. (Trials are indicated in the legend.) The Rf values
were taken from [14,21].
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inactivation of homoaconitase, a superoxide-sensitive 4Fe–4S
cluster enzyme found in the mitochondrial matrix [5]. In light of
these previous ﬁndings, we wondered whether MnTE-2-PyP5þ
and especially MnTnHex-2-PyP5þ were localizing to the mito-
chondria while the other compounds were more evenly distrib-
uted between the mitochondrial and cytosolic compartments. If
so, this could explain the observed differences in levels of rescue
exerted by the mimics upon the growth of sod1Δ yeast in SD-Lys
and SD-Met. Since the MnTnHex-2-PyP5þ was designed to be
more lipophilic, this experiment would also show that its design
had the same intended consequences.
To test this hypothesis, we isolated cytosolic and mitochondrial
fractions from wild-type yeast cells treated with 10 mM MnTM-
2-PyP5þ MnTE-2-PyP5þ , MnTnBu-2-PyP5þ or MnTnHex-2-PyP5þ and
measured the concentrations of these compounds in each fraction.
The values obtained were normalized to the protein concentration
in the sample. The results in Fig. 4 show that MnTnHex-2-PyP5þ
exhibits a very strong preference for a mitochondrial location,
MnTnBu-2-PyP5þ shows a moderate preference, while MnTM-2-
PyP5þ , MnTE-2-PyP5þ are more evenly distributed.
Further analysis of our measurements indicated that the degree
of mitochondrial localization of each Mn porphyrin mimic roughly
correlates with known measurements of its overall lipophilicity, or
thin layer chromatography Rf value [14,16] in Fig. 5.
Thus, we see an overall positive correlation between lipophi-
licity and mitochondrial localization in our data, but it is not linear
(at least in this method of plotting). MnTnHex-2-PyP5þ localizes
far more strongly to the mitochondria than the others, and there is
some discrepancy between the relative activities of each in the
auxotrophy rescue assays (see Discussion section).
The toxicity of these mimics has been an issue in other systems.
For example, E. coli treated with MnTnHex-2-PyP5þ did not grow
in liquid cultures unless the concentration was substantially
reduced [16]. We noted no such effect on liquid cultures of yeast,0
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Fig. 4. Distribution of Mn porphyrin mimic in mitochondria (aqua bars) and cytosol
(orange bars) isolated fromwild-type S. cerevisiae grown in SDC for 24 h at 220 rpm
in 30 °C with 10 mM MnTM-2-PyP5þ (TM), MnTE-2-PyP5þ (TE), MnTnBu-2-PyP5þ
(Bu), or MnTnHex-2-PyP5þ (Hex). Each mimic distribution value displayed was
determined using measurements from at least two trials, with error bars repre-
senting standard deviation. Concentrations of the Mn porphyrin mimics were
measured using high-pressure liquid chromatography and then normalized to
protein concentrations determined via Bradford assays in the respective mitochon-
drial and cytosolic fractions. Student 2-tailed T-tests were performed; the differ-
ence between mitochondrial and cytosolic concentration was signiﬁcant (Po0.05)
in the cases of Bu and hex only.but, in order to determine whether the compounds had any
toxicity in yeast, a more stringent plated colony formation assay
was performed. Wild type and sod1Δ yeast were treated with the
series of mimics for an hour and then washed, spread on YPD
plates and grown in air. After 24 h colonies were counted. Only the
most lipophilic mimic, MnTnHex-2-PyP5þ showed any inhibition
of colony formation (Fig. 6), and that inhibition was far from
complete, especially for the sod1Δ strain. We do not understand
why the WT strain seems to be more sensitive than the sod1Δ
strain to MnTnHex-2-PyP5þ . One possibility is that the higher
mitochondrial number and increased reliance on respiration that
is observed in sod1Δ strains during glucose growth [3] could make
them more resistant to this compound, which heavily accumulates
in mitochondria. It should be noted that if the 1-h drug treatment
was carried out in water rather than liquid growth medium the
compounds were far more toxic (data not shown).Discussion
In this paper we examined the biological efﬁcacy of a series of
manganese porphyrin-based SOD mimics of increasing lipophili-
city, and we related their effectiveness to their tendency to localize
to the mitochondria vs. the cytoplasm. It should be noted that this
is the only study to date that (1) examines both cytosolic and
mitochondrial concentrations a logically graduated series of mi-
mics from the same samples and that (2) relates this localization to
the mimic's ability to replace the biological activity of SOD1 in
yeast lacking this protein.
Direct measurements of the speciﬁc concentrations of these
compounds inside the mitochondria and cytosol of yeast cells
were performed. We demonstrated that the degree of the mito-
chondrial localization of a mimic correlates with its overall
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Fig. 6. Plated toxicity assay examining effects of SOD mimic at 30 mM on colony
formation for WT (black bars) and sod1Δ yeast (gray bars). Cells were treated with
30 mM of the indicated SOD mimic in SDC for 1 h and then placed on YPD plates.
Control samples had no mimic. Values shown are the averages of the percentages
calculated from two independent cultures (with exception of WT treated with
MnTnHex-2-PyP5þ and MnTE-2-PyP5þ , for which there was only one culture in
this experiment). Percentage colony formation, relative to WT untreated control is
shown. Student 2-tailed T-tests were performed. The difference between control
and treated samples was not signiﬁcant (Po0.05) except in the case of Hex.
A.M. Li et al. / Redox Biology 3 (2014) 1–6 5lipophilicity (Fig. 5). That is, the higher the lipophilicity, the higher
the concentration of mimic within mitochondria, as compared to
the cytosol. The most lipophilic mimic in fact showed a startlingly
high mitochondrial to cytoplasmic ratio.
The relationship of lipophilicity to biological efﬁcacy is more
complex. The bioavailability of SOD mimics is important in
determining their therapeutic signiﬁcance and can be affected by
biological factors, including, uptake, intracellular transport me-
chanisms and ﬁnal localization. In our hands, the least lipophilic
compound in our series, MnTM-2-PyP5þ , was the most effective,
fully rescuing growth in either SD-Met and SD-Lys, while the third
in the series, MnTnBu-2-PyP, was the least effective, barely rescu-
ing in either medium. The second and fourth members of the
series, MnTE-2-PyP5þ and MnTnHex-2-PyP5þ , were intermediate
in effectiveness (Fig. 3).
The biological activity of MnTnBu-2-PyP5þ was unexpectedly low,
and there are two factors that may help explain these results. First, the
intrinsic (in vitro) activity level of MnTnBu-2-PyP5þ is lower than that of
MnTnHex-2-PyP5þ , MnTM-2-PyP5þ , or MnTE-2-PyP5þ [14]. This lower
activity is proposed to result from unfavorable steric effects due to the
n-butyl pyridyl substituents. The longer, more hydrophobic alkyl chains
of MnTnHex-2-PyP5þ are proposed to desolvate the metal center in a
way that increases the redox potential and overcomes the unfavorable
steric effects, increasing its activity [13]. Second, we found that the
cellular concentration, especially in the cytoplasm, was low (Fig. 4). This
difference may be due to differences in the way the different com-
pounds interact with biological transporters, membranes, and pores.
For example, MnTM-2-PyP5þ may be small enough to be taken up
through a pore for charged compounds, while MnTnHex-2-PyP5þ may
be lipophilic enough to slip in through the membrane (or indeed
remain in the membrane). MnTnBu-2-PyP5þ may be too big for that
pore but still too charged to easily enter the lipid bilayer, potentially
explaining its reduced accumulation and activity.
Each of the mimics restored growth of sod1Δ strains in liquid
complete medium to close to wild type levels (Fig. 2 and [15]).
When the more stringent tests of growth without lysine or
methionine (amino acid auxotrophies) are applied, efﬁcacy didnot fully follow lipophilicity. Because we can distinguish mito-
chondrial from cytosolic effects functionally via the differential
rescue of the methionine and lysine auxotrophies, we can gain
further insight.
Interestingly, if we compare the lysine auxotrophy rescue by
MnTE-2-PyP5þ with that by MnTnHex-2-PyP5þ , we can conclude
that the large accumulation of MnTnHex-2-PyP5þ inside the
mitochondria renders it far better at rescuing the lysine auxotro-
phy than MnTE-2-PyP5þ . Thus this result supports the idea that
the lysine auxotrophy is mitochondrially based and suggests that
cell protection can be effectively enhanced by targeting SOD
mimics to the mitochondria to increase localized antioxidant
activity.
We previously proposed that the lysine auxotrophy of sod1Δ
yeast is due to inhibition of homoaconitase in mitochondria of
sod1Δ yeast. Homoaconitase contains exposed iron–sulfur clusters,
which are very sensitive to oxidation by superoxide, and its
activity is strongly reduced in sod1Δ strains of yeast [5]. However,
this may not be the whole story. The rather complex regulation of
the early parts of the lysine biosynthetic pathway are carried out
in the nucleus and mitochondria. In S. pombe, the lysine auxo-
trophy in strains lacking CuZnSOD appears to be due to inactiva-
tion of homocitrate synthase [6]. While this inactivation has not
been observed in S. cerevisiae, overexpression of the same enzyme
(which in S. cerevisiae is coded for by the nearly identical lys20 and
lys21 genes and is found in the nucleus) improves growth of sod1Δ
strains in medium lacking lysine [4]. Iron metabolism may play a
role as well. Sod1Δ yeast have an increased iron demand, turn on
high afﬁnity iron transport [22], and accumulate an oxidized form
of EPR-detectable “free iron” which is not thought to be bio-
available [23]. Thus it is possible, or even likely, that the sod1Δ
mutation triggers an iron-sparing program, for which aconitase
and homoaconitase would be logical targets.
Lysine biosynthesis is also inﬂuenced by retrograde signaling
through the RTG pathway, which senses respiratory dysfunction in
the mitochondria and alters nuclear gene expression to maintain
the supply of biosynthetic intermediates (e.g. alpha ketogluterate,
glutamine) and lysine. Under normal conditions, MKS1 functions
as an inhibitor of the RTG pathway ([24], reviewed in [25]).
Constitutive induction of the RTG pathway through mutations in
MKS1 has been shown to relieve the aerobic lysine auxotrophy of
sod1Δ strains, indicating a possible involvement of this pathway
[26]. (The role of this pathway in explaining the mimic effects is
questionable, however, since if the sod1Δ mutation induced the
RTG pathway it should bypass the lysine auxotrophy.) In any case,
each of these mechanisms plays out in the mitochondria, so the
increased localization of the Hex compound to the mitochondria
can explain its preferential rescue of the lysine auxotrophy.
The generally accepted explanation for the methionine auxotrophy
of sod1Δ yeast is that it is due to a cytosolic shortage of reducing
equivalents in the form of NADPH, which are required to synthesize
methionine [20]. Thus, overexpression of ZWF1 (G6PDH, which
catalyzes the ﬁrst step in the pentose phosphate pathway) improves
growth of sod1Δ strains by increasing ﬂux through that pathway,
resulting in increased NADPH generation. Furthermore, work by the
Bilinski laboratory [27] supports this mechanism by showing that the
methionine auxotrophy is better rescued than the lysine auxotrophy
by redox-active agents such as cysteine, glutathione, N-acetyl cysteine
and ascorbate, which are orders of magnitude less strong superoxide
scavengers than SOD but do accumulate in the cytosol and feed into
the supply of cellular reducing power. Our results with MnTM-2-
PyP5þ and MnTE-2-PyP5þ that both accumulate in the cytosol ﬁt well
with this mechanism.
MnTnHex-2-PyP5þ and the even more lipophilic MnTnOct-
2-PyP5þ were reported to be quite toxic to SOD-replete and
SOD-deﬁcient E. coli [14,16], inhibiting growth at concentrations
A.M. Li et al. / Redox Biology 3 (2014) 1–66above 1 mM. While yeast are more resistant, these experimental
ﬁndings are consistent with our toxicity assay results which
showed that MnTnHex-2-PyP5þ inhibits colony [28] formation of
wild type yeast and sod1Δ yeast (Fig. 6). The observed effects on E.
coli were suggested to result from the compounds acting as
detergents inside the cells, something that could occur in mito-
chondria as well.
Our results in yeast agree well with ﬁndings in mice. First, in
pharmaco-kinetic studies, MnTnHex-2-PyP5þ showed much bet-
ter tissue penetration and retention than MnTE-2-PyP5þ , due to its
higher lipophilicity [28]. In addition, biological activity was shown
when a related Mn porphyrin (MnTnBuOE-2-PyP5þ) was found to
reduce the cardiac toxicity of the redox active drug Doxorubicin
[29] and to substitute for the mitochondrial enzyme MnSOD in
MnSOD knock-down mice [30].
Overall, our results indicate that subcellular localization plays
an important role in determining the efﬁcacy of SOD mimicking
drugs against particular targets and that increasing lipophilicity
can direct such compounds to the mitochondria. Along with
increasing our understanding of superoxide toxicity in yeast, these
results may help direct development of more effective redox
therapeutics for humans.Acknowledgments
This work was supported by the National Institutes of Health
Grant DK46828 (to JSV), NRSA Grant number GM077083 to JM,
and to AML, a Jeanette Duval Scholarship (UCLA), a Senior Under-
graduate Research Scholarship Program Fellowship (UCLA), and an
Undergraduate Summer Research Program Fellowship (American
Heart Association, Western States Afﬁliate). Ivan Spasojevic ac-
knowledges the NIH/NCI Duke Comprehensive Cancer Center Core
Grant (5-P30-CA14236-29).References
[1] Y. Sheng, I.A. Abreu, D.E. Cabelli, M.J. Maroney, A.F. Miller, M. Teixeira,
J.S. Valentine, Superoxide dismutases and superoxide reductases, Chemical
Reviews 114 (2014) 3854–3918. http://dx.doi.org/10.1021/cr4005296 24684599.
[2] E.B. Gralla, Superoxide dismutase: studies in the yeast Saccharomyces cerevi-
siae, in: J.G. Scandalios (Ed.), Oxidative Stress and the Molecular Biology of
Antioxidant Defenses, Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY, 1997, pp. 495–525.
[3] S. Sehati, M.H. Clement, J. Martins, L. Xu, V.D. Longo, J.S. Valentine, E.B. Gralla,
Metabolic alterations in yeast lacking copper–zinc superoxide dismutase, Free
Radical Biology & Medicine 50 (2011) 1591–1598. http://dx.doi.org/10.1016/j.
freeradbiomed.2011.03.004 21397007.
[4] M.H. Clement, Uncovering targets of superoxide in the budding yeast Sacchar-
omyces cerevisiae (doctoral dissertation), UCLA, 2008.
[5] M.A. Wallace, L.L. Liou, J. Martins, M.H. Clement, S. Bailey, V.D. Longo, J.
S. Valentine, E.B. Gralla, Superoxide inhibits 4Fe–4S cluster enzymes involved
in amino acid biosynthesis. Cross-compartment protection by CuZn-super-
oxide dismutase, Journal of Biological Chemistry 279 (2004) 32055–32062.
http://dx.doi.org/10.1074/jbc.M403590200 15166213.
[6] E.S. Kwon, J.H. Jeong, J.H. Roe, Inactivation of homocitrate synthase causes
lysine auxotrophy in copper/zinc-containing superoxide dismutase-deﬁcient
yeast Schizosaccharomyces pombe, Journal of Biological Chemistry 281 (2006)
1345–1351. http://dx.doi.org/10.1074/jbc.M506611200 16299000.
[7] A.R. Reddi, V.C. Culotta, SOD1 integrates signals from oxygen and glucose to
repress respiration, Cell 152 (2013) 224–235. http://dx.doi.org/10.1016/j.
cell.2012.11.046 23332757.
[8] T. Fukai, M. Ushio-Fukai, Superoxide dismutases: role in redox signaling,
vascular function, and diseases, Antioxidants & Redox Signaling 15 (2011)
1583–1606. http://dx.doi.org/10.1089/ars.2011.3999 21473702.
[9] B. Halliwell, J.M.C.. Gutteridge, Free Radicals in Biology and Medicine, Oxford
University Press, New York, NY., 2007.
[10] I. Batinic-Haberle, A. Tovmasyan, E.R. Roberts, Z. Vujaskovic, K.W. Leong,
I. Spasojevic, SOD therapeutics: latest insights into their structure–activity
relationships and impact on the cellular redox-based signaling pathways,Antioxidants & Redox Signaling 20 (2014) 2372–2415. http://dx.doi.org/
10.1089/ars.2012.5147 23875805.
[11] I. Batinic-Haberle, I. Spasojevic, Complex chemistry and biology of redox-
active compounds, commonly known as SOD mimics, affect their therapeutic
effects, Antioxidants & Redox Signaling 20 (2014) 2323–2325. http://dx.doi.
org/10.1089/ars.2014.5921 24650329.
[12] A. Tovmasyan, H. Sheng, T. Weitner, A. Arulpragasam, M. Lu, D.S. Warner,
Z. Vujaskovic, I. Spasojevic, I. Batinic-Haberle, Design, mechanism of action,
bioavailability and therapeutic effects of mn porphyrin-based redox modula-
tors, Medical Principles and Practice: International Journal of the Kuwait
University, Health Science Centre 22 (2013) 103–130. http://dx.doi.org/
10.1159/000341715 23075911.
[13] I. Batinić-Haberle, Manganese porphyrins and related compounds as mimics
of superoxide dismutase, Methods in Enzymology 349 (2002) 223–233
11912911.
[14] A. Okado-Matsumoto, I. Batinić-Haberle, I. Fridovich, Complementation of
SOD-deﬁcient Escherichia coli by manganese porphyrin mimics of superoxide
dismutase activity, Free Radical Biology & Medicine 37 (2004) 401–410. http:
//dx.doi.org/10.1016/j.freeradbiomed.2004.04.040 15223074.
[15] W. Munroe, C. Kingsley, A. Durazo, E.B. Gralla, J.A. Imlay, C. Srinivasan, J.
S. Valentine, Only one of a wide assortment of manganese-containing SOD
mimicking compounds rescues the slow aerobic growth phenotypes of both
Escherichia coli and Saccharomyces cerevisiae strains lacking superoxide
dismutase enzymes, Journal of Inorganic Biochemistry 101 (2007) 1875–1882.
http://dx.doi.org/10.1016/j.jinorgbio.2007.07.008 17723242.
[16] A. Tovmasyan, J.S. Reboucas, L. Benov, Simple biological systems for assessing
the activity of superoxide dismutase mimics, Antioxidants & Redox Signaling
20 (2014) 2416–2436. http://dx.doi.org/10.1089/ars.2013.5576 23964890.
[17] E.B. Gralla, J.S. Valentine, Null mutants of Saccharomyces cerevisiae Cu,Zn
superoxide dismutase: characterization and spontaneous mutation rates,
Journal of Bacteriology 173 (1991) 5918–5920 1885557.
[18] C. Kaiser, S. Michaelis, A. Mitchell, Methods in Yeast Genetics, Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY, 1994.
[19] B.S. Glick, L.A. Pon, Isolation of highly puriﬁed mitochondria from Sacchar-
omyces cerevisiae, Methods in Enzymology 260 (1995) 213–223. http://dx.doi.
org/10.1016/0076-6879(95)60139-2 8592446.
[20] K.H. Slekar, D.J. Kosman, V.C. Culotta, The yeast copper/zinc superoxide
dismutase and the pentose phosphate pathway play overlapping roles in
oxidative stress protection, Journal of Biological Chemistry 271 (1996)
28831–28836. http://dx.doi.org/10.1074/jbc.271.46.28831 8910528.
[21] I. Kos, J.S. Rebouças, G. DeFreitas-Silva, D. Salvemini, Z. Vujaskovic, M.
W. Dewhirst, I. Spasojević, I. Batinić-Haberle, Lipophilicity of potent porphyr-
in-based antioxidants: comparison of ortho and meta isomers of Mn(III)
N-alkylpyridylporphyrins, Free Radical Biology & Medicine 47 (2009) 72–78.
http://dx.doi.org/10.1016/j.freeradbiomed.2009.04.002 19361553.
[22] J.M. De Freitas, A. Liba, R. Meneghini, J.S. Valentine, E.B. Gralla, Yeast lacking
CuZn superoxide dismutase show altered iron homeostasis. Role of oxida-
tive stress in iron metabolism, Journal of Biological Chemistry 275 (2000)
11645–11649. http://dx.doi.org/10.1074/jbc.275.16.11645 10766782.
[23] C. Srinivasan, A. Liba, J.A. Imlay, J.S. Valentine, E.B. Gralla, Yeast lacking superoxide
dismutase(s) show elevated levels of “free iron” as measured by whole cell
electron paramagnetic resonance, Journal of Biological Chemistry 275 (2000)
29187–29192. http://dx.doi.org/10.1074/jbc.M004239200 10882731.
[24] I. Dilova, C.Y. Chen, T. Powers, Mks1 in concert with TOR signaling negatively
regulates RTG target gene expression in S. cerevisiae, Current Biology 12
(2002) 389–395. http://dx.doi.org/10.1016/S0960-9822(02)00677-2 11882290.
[25] Z. Liu, R.A. Butow, Mitochondrial retrograde signaling, Annual Review
of Genetics 40 (2006) 159–185. http://dx.doi.org/10.1146/annurev.genet.40.
110405.090613 16771627.
[26] L.T. Jensen, R.J. Sanchez, C. Srinivasan, J.S. Valentine, V.C. Culotta, Mutations in
Saccharomyces cerevisiae iron–sulfur cluster assembly genes and oxidative stress
relevant to Cu,Zn superoxide dismutase, Journal of Biological Chemistry 279
(2004) 29938–29943. http://dx.doi.org/10.1074/jbc.M402795200 15107423.
[27] E. Zyracka, R. Zadrag, S. Kozioł, A. Krzepiłko, G. Bartosz, T. Biliński, Yeast as a
biosensor for antioxidants: simple growth tests employing a Saccharomyces
cerevisiaemutant defective in superoxide dismutase, Acta Biochimica Polonica
52 (2005) 679–684 16175242.
[28] T. Weitner, I. Kos, H. Sheng, A. Tovmasyan, J.S. Reboucas, P. Fan, D.S. Warner,
Z. Vujaskovic, I. Batinic-Haberle, I. Spasojevic, Comprehensive pharmacokinetic
studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-
PyP5þ and MnTnHex-2-PyP5þ , Free Radical Biology & Medicine 58 (2013)
73–80. http://dx.doi.org/10.1016/j.freeradbiomed.2013.01.006 23328731.
[29] Y. Zhao, S. Miriyala, L. Miao, M. Mitov, D. Schnell, S.K. Dhar, J. Cai, J.B. Klein,
R. Sultana, D.A. Butterﬁeld, M. Vore, I. Batinic-Haberle, S. Bondada, D.K. St
Clair, Redox proteomic identiﬁcation of HNE-bound mitochondrial proteins in
cardiac tissues reveals a systemic effect on energy metabolism after doxor-
ubicin treatment, Free Radical Biology & Medicine 72 (2014) 55–65. http://dx.
doi.org/10.1016/j.freeradbiomed.2014.03.001 24632380.
[30] A.K. Holley, Y. Xu, T. Noel, V. Bakthavatchalu, I. Batinic-Haberle, D.K. St Clair,
Manganese superoxide dismutase-mediated inside-out signaling in HaCaT
human keratinocytes and SKH-1 mouse skin, Antioxidants & Redox Signaling
20 (2014) 2347–2360. http://dx.doi.org/10.1089/ars.2013.5204.
